US Federal House Bill HB5509

US Federal 2025-2026 Regular Session

• Introduced: 9/19/25
• Refer: 9/19/25

Caption

Safe Step Act

Impact

The implementation of HB5509 would significantly alter how health plans handle requests for medication step therapy exceptions. By instituting clear timelines for responses, including expedited reviews in cases where life or health is at risk, the law is intended to protect patient interests and ensure access to necessary medications without unnecessary delays. If enacted, the bill would require plans to report on exception requests and outcomes, fostering accountability and transparency in how these protocols are managed.

Summary

House Bill 5509, known as the Safe Step Act, seeks to amend the Employee Retirement Income Security Act of 1974 by instituting a mandatory exceptions process for group health plans and health insurance issuers regarding medication step therapy protocols. The bill requires that if a health plan necessitates a patient to try a preferred drug before covering a prescribed non-preferred drug, the patient or their healthcare provider must have the ability to request an exception. This process aims to provide a fair and transparent avenue for patients who might face adverse effects or ineffectiveness from first-line treatments.

Contention

Despite its intentions, the Safe Step Act is not without contention. Critics may argue that the added requirements for plans could potentially lead to increased administrative burdens and costs for insurance companies. Furthermore, there could be disagreements regarding how effectively these exceptions are handled in practice, with potential concerns about delays in care or inadequate coverage of requests. Supporters, on the other hand, contend that these measures ensure patients receive the most appropriate treatment without arbitrary barriers that could jeopardize their health.